Navigation Links
Myriant Technologies LLC Selected for $50 Million Award for Succinic Acid Biorefinery Project
Date:12/7/2009

QUINCY, Mass., Dec. 7 /PRNewswire/ -- Myriant Technologies LLC (as successor to BioEnergy International), a leading biotech developer and manufacturer of renewable biochemicals, has been selected by the U.S. Department of Energy (DOE) to receive up to $50 million for its planned biobased Succinic Acid facility in Louisiana. Notably, among the 19 integrated biorefinery projects that won funding or loan guarantees, Myriant was the only award focused exclusively on biobased chemicals rather than biofuels.

(Logo: http://www.newscom.com/cgi-bin/prnh/20091021/NE96331LOGO )

The DOE and other third-party studies have previously identified biobased Succinic Acid as a priority among the top 12 chemicals by market size that can be derived from biomass. Succinic Acid is used in a wide variety of applications including plastics, fibers, polyesters and pigments.

Myriant's production of biobased Succinic Acid will utilize both local sorghum and carbon dioxide (CO2) to displace petroleum-based feedstocks, using less energy than its petroleum alternative. In addition to the energy savings, by consuming CO2 rather than producing it via oil refining methods, Myriant's process dramatically reduces lifecycle greenhouse gas emissions.

"We are grateful for the validation of our technology embodied in the award by the DOE," said Stephen J. Gatto, Chairman and Chief Executive Officer of Myriant. "We applaud their recognition of the importance of biobased chemicals as a leading component of biorefineries. Our Succinic Acid platform provides a "win-win" solution in terms of cost, environmental benefits and reduction in our dependence on imported oil and puts critical jobs to work right here in the United States."

The award will help fund the construction of Myriant's Succinic Acid plant at the Port of Lake Providence, Louisiana. "The Port and the State of Louisiana have been extraordinary partners, and we expect the site, immediately adjacent to the Mississippi River, to be the foundation of a large biotech corridor in Louisiana," added Mr. Gatto. "We're very excited about bringing this technology and over 250 construction and full time operating jobs to the community."

"The Port of Lake Providence is tremendously excited to be working with Myriant on this very important project," added Wyly Gilfoil, Director of the Lake Providence Port Commission. "We're delighted to see the assets of the Port and the region used in this manner to bring much needed high tech industries and jobs to the community."

About Myriant Technologies

With a world-renowned team of molecular biologists, engineers and chemists, Myriant utilizes proprietary technology to advance the development of low-cost cellulosic sugars for the sustainable manufacturing of high-value specialty chemicals. The company's D(-) lactic acid started production at commercial scale in June 2008 for use in polylactic acid. Myriant will next begin commercial production of its second product, biobased Succinic Acid; samples are currently available by contacting productinfo@myriant.com. Myriant is headquartered in Quincy, Massachusetts. Further information is available at www.myriant.com.


Contact:  Samuel G. McConnell
          Sr. Vice President, Corporate Development
          617-657-5207

SOURCE Myriant Technologies LLC


'/>"/>
SOURCE Myriant Technologies LLC
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Myriant Technologies LLC, Uhde Corporation of America and Uhde GmbH Announce Alliance for Engineering, Procurement & Construction of World Scale Renewable Succinic Acid Plants
2. Myriant Technologies LLC Announces Appointment of Science Advisory Board Members
3. BioEnergy International, LLC Announces Formation of Myriant Technologies LLC
4. Reportlinker Adds Drug Discovery Technologies - A Global Update of Market Trends & Opportunities
5. Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies
6. Harvest Technologies Announces Trial Results in its India Study Using BMAC to Treat Patients With Non-Reconstructable Critical Limb Ischemia
7. Palatin Technologies, Inc. Issued U.S. Patent for Heart Failure Drug Candidate
8. Acuo Technologies Announces Contract for Vendor Neutral Archive With Allina Hospitals and Clinics
9. Promega and SwitchGear Publish Findings from Combined Technologies that Correlate Binding Events and Transcriptional Activity
10. Senesco Technologies, Inc. Announces Management Change
11. Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2010 Results; Teleconference and Webcast to be held on November 16, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... Research and Markets has announced the addition of the "Nanobiotechnology ... ... separate comprehensive analytics for the US, Japan , ... and forecasts are provided for the period 2015 through 2022. Also, ... and analytics are derived from primary and secondary research. This report ...
(Date:2/17/2017)... ... February 17, 2017 , ... Academy of Model Aeronautics ... leading maker of unmanned aircraft systems (UAS), are launching a joint program to ... effectively, and support educational outreach efforts. , AMA and DJI will collaborate on ...
(Date:2/16/2017)... 16, 2017  ImMAGE Biotherapeutics (OTCMKTS: IMMG), an early-stage biotechnology ... a better treatment for triple negative breast cancer (TNBC), announced ... France program. The YEi Start in ... to help entrepreneurs grow their business in France ... American companies selected to complete an intensive one week immersion ...
(Date:2/16/2017)... -- Research and Markets has announced the ... report to their offering. ... The study scope ... plasmids, chassis organisms, synthetic cells, production systems), enabling technologies ... and specialty media) and enabled technologies (biofuels, chemicals, pharmaceuticals, ...
Breaking Biology Technology:
(Date:2/8/2017)... , Feb. 7, 2017 The ... largely by the confluence of organizations, desires to ... for knowledge-based systems (password and challenge questions), biometrics ... and government systems. The market is driven by ... demarcation between consumer and enterprise uses cases, with ...
(Date:2/7/2017)... , Feb. 7, 2017 Zimmer Biomet ... in musculoskeletal healthcare, will present at the LEERINK Partners ... York Palace Hotel on Wednesday, February 15, 2017 at ... webcast of the presentation can be accessed at ... following the conference via Zimmer Biomet,s Investor Relations website ...
(Date:2/3/2017)... 3, 2017  Texas Biomedical Research Institute announced that its ... Schlesinger as the Institute,s new President and CEO. Dr. ... 31, 2017. He is currently the Chair of the Department ... for Microbial Interface Biology at Ohio State University. ... President and CEO of Texas Biomed," said Dr. James ...
Breaking Biology News(10 mins):